| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
180,310,000 |
| Market
Cap: |
41.24(B) |
| Last
Volume: |
799,597 |
Avg
Vol: |
865,460 |
| 52
Week Range: |
$191.51 - $228.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
39,326 |
485,736 |
| Total Sell Value |
$0 |
$0 |
$8,245,949 |
$88,282,436 |
| Total People Sold |
0 |
0 |
7 |
8 |
| Total Sell Transactions |
0 |
0 |
18 |
71 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dansey Roger D |
See Remarks |
• – – |
2019-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,768 |
83,009 |
|
- |
|
| Siegall Clay B |
See Remarks |
• • – |
2019-02-08 |
4 |
AS |
$64.49 |
$1,313,126 |
D/D |
(20,148) |
732,613 |
|
- |
|
| Siegall Clay B |
See Remarks |
• • – |
2019-02-08 |
4 |
OE |
$12.16 |
$245,000 |
D/D |
20,148 |
740,690 |
|
- |
|
| Gryska David W |
Director |
– • – |
2019-01-08 |
4 |
AS |
$65.04 |
$325,200 |
D/D |
(5,000) |
45,050 |
|
- |
|
| Gryska David W |
Director |
– • – |
2019-01-08 |
4 |
OE |
$12.76 |
$63,800 |
D/D |
5,000 |
50,050 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2019-01-08 |
4 |
AS |
$64.21 |
$1,324,237 |
D/D |
(20,148) |
732,613 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2019-01-08 |
4 |
OE |
$12.16 |
$245,000 |
D/D |
20,148 |
735,613 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-12-10 |
4 |
AS |
$59.15 |
$1,203,545 |
D/D |
(20,148) |
732,613 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-12-10 |
4 |
OE |
$12.16 |
$245,000 |
D/D |
20,148 |
733,313 |
|
- |
|
| Himes Vaughn B |
Chief Technical Officer |
• – – |
2018-11-30 |
4 |
OE |
$12.00 |
$60,000 |
D/D |
5,000 |
177,329 |
|
- |
|
| Himes Vaughn B |
Chief Technical Officer |
• – – |
2018-11-30 |
4 |
AS |
$62.09 |
$310,718 |
D/D |
(5,000) |
172,329 |
|
- |
|
| Cline Darren S |
EVP, Commercial |
• – – |
2018-11-29 |
4 |
S |
$62.88 |
$440,160 |
D/D |
(7,000) |
72,556 |
|
- |
|
| Cline Darren S |
EVP, Commercial |
• – – |
2018-11-21 |
4 |
S |
$56.68 |
$236,204 |
D/D |
(4,167) |
79,556 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-11-08 |
4 |
AS |
$61.29 |
$1,239,873 |
D/D |
(20,148) |
732,613 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-11-08 |
4 |
OE |
$12.16 |
$245,000 |
D/D |
20,148 |
746,091 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2018-10-30 |
4 |
OE |
$8.38 |
$41,900 |
D/D |
5,000 |
37,205 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-10-08 |
4 |
AS |
$76.96 |
$1,559,231 |
D/D |
(20,148) |
732,613 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-10-08 |
4 |
OE |
$12.16 |
$245,000 |
D/D |
20,148 |
738,824 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-09-17 |
4 |
AS |
$76.36 |
$1,548,196 |
D/D |
(20,148) |
732,613 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-09-17 |
4 |
OE |
$12.16 |
$245,000 |
D/D |
20,148 |
734,003 |
|
- |
|
| Dansey Roger D |
Chief Medical Officer |
• – – |
2018-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,898 |
77,241 |
|
- |
|
| Himes Vaughn B |
Chief Technical Officer |
• – – |
2018-09-07 |
4 |
S |
$76.15 |
$384,962 |
D/D |
(5,000) |
177,329 |
|
- |
|
| Himes Vaughn B |
Chief Technical Officer |
• – – |
2018-09-07 |
4 |
OE |
$12.00 |
$60,000 |
D/D |
5,000 |
182,329 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2018-08-30 |
4 |
A |
$0.00 |
$0 |
D/D |
95,981 |
732,613 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2018-08-30 |
4 |
A |
$0.00 |
$0 |
D/D |
20,715 |
194,280 |
|
- |
|
1805 Records found
|
|
Page 22 of 73 |
|
|
